Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
malignant pleural effusion
MeSH D016066 - malignant pleural effusion
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D010997:
Pleural neoplasms
0 Companies
0 Drugs
Success rate
D010996:
Pleural effusion
55 Companies
3 Drugs
$
Success rate
D016066:
Malignant pleural effusion
2 Companies
1 Drug
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
62
%
13/21
Phase 2
29
%
7/24
Phase 3
67
%
6/9
Approved:
2
Overall Success rate:
12%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Recordati
Mechlorethamine
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use